0

Is Cost-Effectiveness Analysis Racist?

Performing and using cost-effectiveness analyses is a core activity for many of us working in HEOR. Many shortcomings of CEA are well known (it fails to account for budget impact, “real option value”, “the value of hope”, etc.), but CEA as currently performed has an even bigger problem than any of those: equity. Continue Reading

0

Generating evidence for optimal market access – an Executive Interview with Jeff Anderson and Rosemary Jose, OPEN Health

Jeff Anderson is CEO of the Evidence & Access practice and Rosemary Jose leads Strategic Market Access strategy and activities. They talk about current dynamics in the healthcare industry and the challenges of generating evidence for optimal market access. Continue Reading

0

All About the Value, Evidence and Access Marketplace: Interview with Scientist.com Category Experts

Scientist.com, the parent company of HealthEconomics.Com, recently announced the newly rebranded Value, Evidence and Access Marketplace – an online solution that accelerates the sourcing and procurement process for researchers and suppliers of HEOR, RWE and Market Access services. Continue Reading

0

Education Spotlight – Xavier Health Economics & Clinical Outcomes Research

Education Spotlight highlights the unique educational opportunities available in HEOR, Market Access, and RWE/RWD. Below is an interview with Xavier University’s Health Economics & Clinical Outcomes Research program, which prepares students to use comparative research and real-world evidence to make smarter,… Continue Reading